Corey and Christine will provide an update on the commercial launch of Orlynda in the U.S. Corey will also give an update on ...
The research adds to a growing body of evidence that the chemicals are making their way into the environment with detrimental ...
Phase 3 TRANSCEND trial data showed setmelanotide achieved significant BMI reductions in patients with acquired hypothalamic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback